Asia-Pacific Pharmaceutical Contract Manufacturing OrganizationCompanies

Q: How big is the Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market?

The Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market size is expected to reach USD 55.15 billion in 2024 and grow at a CAGR of 8.74% to reach USD 83.85 billion by 2029. Read More

Q: What is the current Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market size?

In 2024, the Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market size is expected to reach USD 55.15 billion. Read More

Q: Who are the key players in Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market?

Recipharm AB , Jubilant Life Sciences Ltd, Thermo Fisher Scientific Inc. (Patheon Inc.), Boehringer Ingelheim Group and Pfizer CentreSource (Pfizer Inc) are the major companies operating in the Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market. Read More

Q: What years does this Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market cover, and what was the market size in 2023?

In 2023, the Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market size was estimated at USD 50.72 billion. The report covers the Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Asia-Pacific Pharmaceutical Contract Manufacturing OrganizationCompanies

This report lists the top Asia-Pacific Pharmaceutical Contract Manufacturing Organization companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Asia-Pacific Pharmaceutical Contract Manufacturing Organization industry.